Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

UNKNOWN

The Effect of Intranasal Administration of Oxytocin on Empathic Abilities.

Lead Sponsor:

Shalvata Mental Health Center

Collaborating Sponsors:

University of Haifa

Conditions:

Schizophrenia

Eligibility:

All Genders

18-45 years

Phase:

PHASE2

Brief Summary

Empathy constitutes one prominent ability of social cognition, which represents the human capability of understanding mental state of the other, and responding in sympathetic way. Two sets of theoreti...

Detailed Description

Social cognition encompasses a wide spectrum of abilities, enabling us to function properly in interpersonal interactions. Empathy constitutes one prominent ability of social cognition, which represen...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (for schizophrenic patients):
  • Range of age between 18 and 45 years.
  • The patient is diagnosed as suffering from schizophrenia by 2 independent psychiatrists, according to DSM-IV criteria.
  • The participant is able to commit to 2 trials with 7 days interval.
  • The participant has been informed orally and in writing and has given his/her written consent.
  • When necessary, a psychiatrist has determined the patient's ability to agree, orally and in writing.
  • Inclusion Criteria (for healthy patients):
  • Range of age between 18 and 45 years.
  • The participant is able to commit to 2 trials with 7 days interval.
  • The participant has been informed orally and in writing and Has given his/her written consent.
  • Exclusion Criteria (for schizophrenic patients):
  • The participant is suffering from other acute, unstable, significant or untreated medical Illness, including arrhythmia and head injury.
  • The participant is suffers from an axis II disorder of DSM-IV.
  • The participant has history of alcohol or drug abuse.
  • The participant is pregnant or breast-feeding.
  • The participant suffers from mental retardation (IQ less than 75).
  • The participant has any disturbance in visuomotor coordination.
  • The participant has smoked a cigarette in the day of the trial.
  • High suicidal risk, as determined by the treating physician.
  • Exclusion Criteria (for healthy patients):
  • The participant is suffering from acute, unstable, significant or untreated medical Illness, including arrhythmia and head injury.
  • The participant has history of alcohol or drug abuse.
  • The participant is pregnant or breast-feeding.
  • The participant suffers from mental retardation (IQ less than 75).
  • The participant has any disturbance in visuomotor coordination.
  • The participant has smoked a cigarette in the day of the trial.

Exclusion

    Key Trial Info

    Start Date :

    May 1 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    January 1 2010

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT00813436

    Start Date

    May 1 2008

    End Date

    January 1 2010

    Last Update

    February 5 2009

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Shalvata Mental Health Center

    Hod HaSharon, Israel